Autoinflammatory & rare systemic diseases

Comparative evaluation of disease activity measures for adult-onset Still’s disease: a multicentre, retrospective, cohort study

RMD OpenPublished Retrospective cohort study

Authors' conclusion

mDAVID and mSDAS demonstrated the most favourable and largely comparable performance profiles across the evaluated metrics, with mDAVID showing greater responsiveness and mSDAS demonstrating a stronger correlation with the articular disease domain.

Study context

Population
Patients with initially active adult-onset Still's disease (AOSD) in an independent multicentre cohort (64% female; mean age 39.4±15.0 years)
Participants
86 patients
Exposure
mDAVID vs mSDAS vs Still Activity Score (SAS) vs Pouchot's Systemic Score (PSS) as AOSD activity measures
Outcome
Criterion validity, AUC vs physician-determined disease activity
Methodological detailsmulticentre, imputed data primary analysis, complete-case sensitivity analysis
  • Multicentre
  • Imputed data primary analysis
  • Complete-case sensitivity analysis

Main finding

As reported in the abstract

GroupAUC
mDAVID0.68
mSDAS0.69
SAS0.68
PSS0.60

AUC

mDAVID0.68
mSDAS0.69
SAS0.68
PSS0.60

Observational data: associations, not effects.

Further findings

OutcomemDAVIDmSDASSASPSS
Responsiveness, Cohen's d (95% CI)0.76 (95% CI 0.30–1.20)0.61 (CI 0.13–1.1)0.46 (CI −0.01–0.90)0.22 (CI −0.30–0.68)
Longitudinal sensitivity to change, marginal R² (95% CI)0.65 (95% CI 0.59–0.70)0.61 (CI 0.55–0.67)0.55 (CI 0.45–0.64)0.61 (CI 0.54–0.67)

Complete-case sensitivity analyses

Similar results to primary (imputed) analysis

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Comparative evaluation of disease activity measures for adult-onset Still’s disease: a multicentre, retrospective, cohort study. RMD Open. Published 4 September 2026. doi:10.1136/rmdopen-2026-007112

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.